Dr. Angelika Niebler, MEP
نویسندگان
چکیده
منابع مشابه
Angelika Amon
Angelika Amon obtained her PhD in 1994 from the University of Vienna for her work on the molecular mechanisms governing cell cycle progression in budding yeast. She then joined the laboratory of Dr. Ruth Lehmann at the Whitehead Institute to investigate germ cell formation in Drosophila. In 1996 Angelika accepted a Whitehead Fellow position to study the mechanisms governing chromosome segregati...
متن کاملAngelika Amon: Conquering the divide
M itosis is a fantastically complex process, but the simple beauty of chromosome segregation can captivate even the untrained eye. When Angelika Amon saw a video of a dividing cell as a schoolgirl in Austria, it set her on a path to a professorship at the Massachusetts Institute of Technology in Cambridge, MA, where she continues to investigate chromosome segregation and the consequences of mit...
متن کاملMetal-enhanced phosphorescence (MEP)
We report the first observation of metal-enhanced phosphorescence (MEP) at low temperature. Silver island films (SiFs) in close proximity to Rose Bengal, significantly enhance the phosphorescence emission intensity. The enhanced phosphorescence intensity is 5-fold brighter from SiFs as compared to a glass control sample at 77 K. In addition, enhanced fluorescence emission and spectral narrowing...
متن کاملMEP - A Media Event Platform
Popular media events of today are likely to attract a big, live audience. Being part of a huge cricket audience, for example, knowing that the event is broadcast to perhaps millions of people, is a truly arousing experience. But the size of the audience and the complexity of events do not come without drawbacks. Spectators find it difficult to be at the right spot at the right time and to grasp...
متن کاملMEP-AST Mepolizumab versus placebo for asthma
Background Mepolizumab is a human monoclonal antibody against interleukin-5 (IL-5), the main cytokine involved in the activation of eosinophils, which in turn causes airway inflammation. Recent studies have suggested these agents may have a role in reducing exacerbations and improving health-related quality of life (HRQoL). There are no recommendations for the use of mepolizumab in adults or ch...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: djbZ
سال: 2012
ISSN: 1866-377X
DOI: 10.5771/1866-377x-2012-3-143